recent
canin
coronaviru
ccov
strain
put
recombin
origin
porcin
transmiss
gastroenter
viru
tgev
shown
widespread
europ
studi
kill
vaccin
tgevlik
ccov
strain
includ
new
subtyp
ccoviib
develop
inactiv
betapropiolacton
emulsif
tm
adjuv
safeti
immunogen
efficaci
develop
vaccin
evalu
vivo
five
beagl
pup
administ
three
week
apart
two
vaccin
dose
wherea
two
anim
serv
unvaccin
control
vaccin
shown
safe
local
neither
system
reaction
observ
first
second
dose
administr
serum
antibodi
ccov
detect
vaccin
start
studi
day
enzymelink
immunosorb
assay
viru
neutralis
test
subsequ
challeng
virul
ccoviib
result
develop
mild
gastroenter
diseas
control
pup
wherea
vaccin
display
clinic
sign
faecal
shed
challeng
viru
occur
treatment
group
vaccin
dog
found
shed
low
viral
titr
comparison
control
develop
vaccin
may
help
control
ccoviibinduc
diseas
activ
viru
circul
environ
kennel
shelter
pathogen
potenti
viru
greater
consequ
predispos
factor
concurr
infect
canin
coronaviru
ccov
member
newli
establish
genu
alphacoronaviru
famili
coronavirida
order
nidoviral
ccov
strictli
relat
felin
coronaviru
type
fcovi
type
ii
fcovii
transmiss
gastroenter
viru
swine
tgev
respiratori
variant
porcin
respiratori
coronaviru
prcov
base
similar
genom
organis
virus
includ
uniqu
viral
speci
ccov
classic
faecalor
rout
transmiss
colonis
top
villi
enter
tract
respons
mild
selflimit
enter
infect
pup
usual
recov
spontan
ccovinduc
diseas
howev
hypervirul
ccov
strain
report
last
year
pantrop
variant
associ
system
sometim
fatal
diseas
pup
natur
experiment
condit
two
ccov
genotyp
identifi
far
name
ccov
type
ccovi
ccov
type
ii
ccovii
genotyp
various
distribut
worldwid
predomin
ccovii
europ
asia
addit
ccov
recombin
origin
ccovii
tgev
identifi
faec
dog
diarrhoea
found
widespread
dog
popul
accordingli
ccovii
classifi
two
subtyp
ccoviia
ccoviib
includ
classic
ccov
tgevlik
strain
respect
subtyp
ccoviib
report
sever
european
countri
well
japan
limit
antigen
crossreact
observ
subtyp
iia
iib
ccov
rais
concern
real
efficaci
ccov
vaccin
avail
market
prepar
subtyp
iia
tgevlik
strain
aim
present
studi
develop
inactiv
vaccin
adjuv
tm
ccoviib
evalu
safeti
immunogen
efficaci
beagl
pup
canin
cell
use
viru
cultiv
grown
dulbecco
minim
essenti
medium
dmem
supplement
foetal
calf
serum
ccoviib
strain
isol
lung
italian
great
dane
pup
hungarian
chihuahua
pup
respect
present
studi
viru
use
vaccin
prepar
wherea
hungarian
strain
serv
challeng
viru
ccoviib
strain
chosen
vaccin
viru
sinc
contain
delet
could
use
futur
vaccin
genet
marker
wherea
use
challeng
viru
sinc
distinct
geograph
origin
two
strain
found
strictli
relat
genet
level
display
nucleotid
ident
nearli
fulllength
genom
viru
isol
lung
sampl
homogenis
wv
dmem
contain
antibiot
penicillin
iuml
streptomycin
gml
amphotericin
b
gml
viral
growth
monitor
constantli
immunofluoresc
assay
use
monoclon
antibodi
mab
bind
n
protein
goat
antimous
igg
conjug
fluorescein
isothiocyan
sigma
aldrich
srl
milan
itali
virus
induc
cytopath
effect
inocul
monolay
test
posit
assay
cell
media
third
serial
passag
collect
centrifug
g
min
remov
cell
debri
aliquot
store
c
use
viral
titr
isol
tcid
ml
viral
suspens
respect
isol
inactiv
betapropiolacton
vv
inactiv
suspens
contain
total
protein
amount
g
ml
determin
spectophomet
analysi
mix
tm
adjuv
novarti
vaccin
diagnost
siena
itali
vaccin
stock
aliquot
dose
store
c
stock
vaccin
test
steril
aerob
anaerob
bacteria
mycoplasma
mycet
use
standardis
method
presenc
contamin
virus
search
viral
suspens
prior
ad
adjuv
mean
rt
pcr
assay
detect
canin
parvoviru
type
canin
distemp
viru
cdv
canin
adenovirus
cadv
canin
herpesviru
rotavirus
reovirus
calicivirus
experiment
studi
perform
accord
european
anim
health
wellb
regul
authoris
italian
ministri
health
author
seven
beagl
pup
hous
infecti
diseas
unit
anim
hospit
faculti
veterinari
medicin
bari
dog
test
neg
ccov
rna
realtim
rtpcr
assay
carri
faec
ccov
antibodi
elisa
test
carri
serum
sampl
dog
hous
individu
separ
box
fed
twice
daili
commerci
dri
dog
food
provid
water
ad
libitum
acclimat
period
one
week
five
anim
pup
vaccin
subcutan
administr
two
dose
three
week
apart
studi
day
ml
experiment
vaccin
wherea
two
dog
pup
maintain
unvaccin
receiv
subcutan
two
dose
ml
steril
salin
solut
placebo
order
assess
inject
site
reaction
vaccin
first
vaccin
administr
right
hand
side
interscapular
space
wherea
second
dose
administ
left
hand
side
day
two
week
booster
administr
anim
administ
total
ml
challeng
materi
isol
titr
approxim
tcid
ml
challeng
dose
establish
accord
previou
studi
ccov
vaccin
approxim
ml
challeng
materi
administ
per
nostril
ml
total
ml
administ
oral
anim
observ
day
challeng
specif
clinic
sign
ccov
infect
singl
veterinarian
awar
treatment
group
assign
respons
daili
clinic
observ
dog
end
anim
phase
studi
day
anim
kept
anim
facil
test
everi
five
day
ccov
shed
faecal
sampl
anim
assign
privat
owner
laboratori
result
indic
anim
shed
ccov
three
consecut
test
vaccin
safeti
evalu
observ
local
system
reaction
vaccin
qualit
assess
inject
site
reaction
made
palpat
inject
site
occurr
pain
andor
reaction
wherea
system
reaction
assess
clinic
inspect
examin
local
system
reaction
perform
twice
day
vaccin
prevaccin
h
postvaccin
daili
four
day
vaccin
administr
vaccin
immunogen
evalu
assess
ccovantibodi
respons
vaccin
dose
administr
vaccin
control
dog
bled
serum
collect
day
day
firstdos
administr
day
booster
administr
day
challeng
antibodi
titr
also
evalu
challeng
studi
day
serum
sampl
store
c
analysi
use
enzymelink
immunosorb
assay
elisa
viru
neutralis
vn
test
previous
describ
elisa
test
microtitr
plate
coat
ccov
antigen
treatment
block
solut
repeat
wash
dilut
plasma
sampl
ad
well
plate
incub
min
c
wash
four
time
incub
min
c
antidog
igggoat
peroxidas
conjug
sigmaaldrich
srl
milan
itali
anoth
wash
cycl
mg
freshli
prepar
substrat
azinodi
sulfon
diammonium
salt
abt
sigmaaldrich
srl
ml
phosphat
citrat
buffer
ph
ad
well
optic
densiti
nm
od
determin
vn
test
serial
twofold
dilut
heatinactiv
sera
mix
tcid
strain
ccoviib
ccoviia
microtitr
plate
preincub
room
temperatur
min
cell
ad
well
plate
read
four
day
incub
c
vn
titr
calcul
use
spearmankarb
method
express
highest
serum
dilut
abl
neutralis
viru
vaccin
efficaci
evalu
challeng
vaccin
dog
virul
tgevlik
strain
two
week
postsecond
vaccin
assess
prevent
reduct
clinic
sign
viral
shed
comparison
unvaccin
control
dog
clinic
examin
perform
dog
daili
data
analyz
use
r
softwar
version
hypothesi
test
conduct
level
signific
twosid
area
curv
auc
faecal
shed
challeng
viru
calcul
group
control
vaccin
statist
signific
evalu
use
mannwhitney
test
prior
analysi
auc
valu
logarithm
transform
mannwhitney
test
also
use
compar
clinic
score
observ
challeng
wherea
vn
antibodi
titr
ccoviia
ccoviib
analys
wilcoxon
test
bacteri
fungal
viral
contamin
detect
tradit
molecular
method
viral
suspens
use
stock
vaccin
thu
confirm
steril
vaccin
batch
local
inject
site
reaction
pain
neither
system
anaphylaxi
convuls
depress
diarrhoea
oedema
enlarg
tabl
report
day
correspond
faecal
shed
curv
lymph
node
vomit
wheal
reaction
observ
vaccin
control
dog
first
second
vaccin
elisa
test
antibodi
ccov
appear
vaccin
dog
studi
day
increas
mean
od
valu
day
fig
vn
antibodi
ccoviib
detect
studi
day
geometr
mean
titr
reach
maxim
prechalleng
titr
day
ccov
antibodi
detect
control
dog
prechalleng
phase
either
elisa
vn
test
challeng
administr
result
increas
antibodi
level
vaccin
anim
rapid
onset
high
antibodi
titr
control
pup
crossneutralis
use
heterolog
viru
ccoviia
vn
antibodi
follow
similar
kinet
titr
significantli
lower
p
fig
clinic
score
viral
shed
challeng
dog
report
fig
challeng
virul
ccoviib
strain
vaccin
dog
display
clinic
sign
except
soft
faec
observ
one
anim
studi
day
day
postchalleng
two
anim
day
contrast
challeng
administr
unvaccin
dog
result
occurr
mild
gastroenter
characteris
liquid
diarrhoea
soft
faec
day
poor
fair
appetit
day
one
control
dog
show
depress
studi
day
day
postchalleng
pup
gain
weight
postchalleng
period
none
show
alter
rectal
temperatur
tabl
mean
clinic
score
vaccin
dog
control
statist
signific
p
challeng
viru
detect
faec
vaccin
dog
mean
day
studi
day
low
viral
titr
reach
maxim
valu
studi
day
mean
viral
rna
load
copi
l
templat
control
shed
ccov
entir
postchalleng
observ
period
day
viral
titr
gener
high
peak
studi
day
mean
viral
titr
copi
l
templat
mean
valu
area
curv
real
time
rtpcr
result
faecal
swab
postchalleng
period
vaccin
unvaccin
dog
respect
p
ccov
strain
antigen
similar
tgev
first
isol
california
outbreak
gastroenter
dog
analog
ccov
strain
tgevlik
identi
fie
year
later
dead
pup
rais
itali
import
eastern
europ
upon
genom
character
viru
found
chimer
gene
end
gene
acquir
tgev
via
recombin
also
viru
associ
form
mild
gastroenter
infect
pup
name
ccoviib
order
distinguish
classic
ccovii
virus
ccoviia
subsequ
studi
show
ccoviib
widespread
europ
highest
frequenc
detect
eastern
countri
limit
antigen
crossreact
demonstr
ccoviia
ccoviib
hypothesis
account
possibl
decreas
efficaci
current
vaccin
base
inactiv
ccoviia
strain
tgevlik
ccov
strain
order
overcom
possibl
limit
exist
ccov
formul
develop
inactiv
tmadjuv
vaccin
prepar
ccoviib
strain
vaccin
found
safe
neither
local
system
reaction
induc
subcutan
inject
beagl
pup
ccoviib
vaccin
immunogen
elicit
seroconvers
inocul
pup
effect
abl
prevent
ccovinduc
diseas
mild
gastroenter
occur
unvaccin
pup
infect
challeng
viru
observ
previou
challeng
studi
inactiv
ccov
vaccin
avail
market
shown
protect
dog
diseas
infect
convers
experiment
modifiedl
viru
mlv
vaccin
administ
oronas
appear
abl
prevent
ccov
diseas
infect
studi
inactiv
ccoviib
vaccin
albeit
complet
protect
infect
abl
decreas
markedli
shed
challengeviru
thu
prevent
spread
virul
strain
environ
possibl
explan
good
vaccin
efficaci
may
reli
tm
adjuv
use
formul
tm
oilinwat
formul
contain
surfact
tween
span
along
squalen
emulsifi
highpressur
condit
adjuv
satisfactorili
includ
vaccin
commonli
use
prevent
season
pandem
influenza
immun
respons
elicit
tm
adjuv
ccoviib
vaccin
term
elisa
od
valu
homolog
vn
antibodi
titr
greater
observ
aluminium
hydroxideadjuv
ccoviia
formul
compar
experiment
mlv
vaccin
higher
efficaci
vaccin
base
tm
adjuv
still
larg
unclear
enhanc
interact
antigen
dendrit
cell
seem
involv
howev
consid
efficaci
commerci
avail
ccov
vaccin
evalu
present
studi
claim
higher
efficaci
tmadjuv
formul
may
bias
differ
age
andor
genet
background
pup
employ
vaccin
trial
dog
ccov
gener
caus
mild
selflimit
infect
restrict
gastrointestin
tract
accordingli
ccov
vaccin
consid
core
vaccin
use
discret
world
small
anim
veterinari
associ
current
recommend
ccov
vaccin
preval
ccovconfirm
clinic
case
rather
low
howev
preval
ccovinduc
enter
diseas
dog
like
larg
underr
diagnosi
ccov
infect
requir
specif
test
avail
laboratori
addit
fatal
diseas
may
occur
consequ
mix
infect
ccov
canin
pathogen
cdv
although
never
prove
vaccin
ccov
reduc
sever
mix
infect
ccov
vaccin
consid
prioriti
set
kennel
anim
shelter
ccov
expect
circul
larg
mix
infect
common
anim
subject
stress
condit
may
trigger
develop
sever
clinic
form
date
still
limit
inform
ccoviib
infect
dog
find
seem
suggest
pathogenet
pattern
new
ccov
subtyp
similar
observ
ccoviia
accordingli
similar
prophylaxi
strategi
could
enact
prevent
control
ccoviibassoci
diseas
dog
oneway
antigen
crossreact
alreadi
shown
neutralis
vitro
ccoviib
ccoviia
confirm
present
studi
antibodi
elicit
recombin
ccov
abl
crossneutralis
partial
heterolog
viru
ccoviia
base
find
well
poor
efficaci
aluminium
hydroxideadjuv
formul
even
ccoviia
could
specul
commerci
avail
vaccin
protect
ccoviib
therefor
pivot
assess
whether
extent
crossprotect
occur
vivo
whether
ccoviib
tgevlik
base
vaccin
may
develop
prevent
ccov
diseas
induc
ccov
subtyp
dog
